<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> SJMN91-06114010 </DOCNO><ACCESS> 06114010 </ACCESS><DESCRIPT>  COMPANY; EARNINGS; CHART  </DESCRIPT><LEADPARA>  3Q 3/31            Fiscal 1991       Fiscal 1990     %chg; Revenues          $13,831,000       $9,798,000       andplus;41; Net income; (loss)            (12,907,000)      (15,862,000)     andplus;19;  Per share         (0.39)           (0.56)           andplus;30;  Cetus Corp. of Emeryville applies the tools ofbiotechnology and the science of immunology to the development of novelpharmaceutical products.  The company is also developing several commercialapplications of its GeneAmp polymerase chain reaction technology. (OTC)  </LEADPARA><SECTION>  Business  </SECTION><HEADLINE>  CETUS  </HEADLINE><MEMO>  Earnings  </MEMO><COUNTRY>  USA  </COUNTRY><EDITION>  Morning Final  </EDITION><CODE>  SJ  </CODE><NAME>  San Jose Mercury News  </NAME><PUBDATE>   910423  </PUBDATE> <DAY>  Tuesday  </DAY><MONTH>  April  </MONTH><PG.COL>  2C  </PG.COL><PUBYEAR>  1991  </PUBYEAR><REGION>  WEST  </REGION><FEATURE>  CHART  </FEATURE><STATE>  CA  </STATE><WORD.CT>  60  </WORD.CT><DATELINE>  Tuesday April 23, 199100114010,SJ1  </DATELINE><COPYRGHT>  Copyright 1991, San Jose Mercury News  </COPYRGHT><LIMLEN>  1  </LIMLEN><LANGUAGE>  ENG  </LANGUAGE></DOC>